FMT Plus Immunotherapy Delivers 80 Percent Response Rate in Advanced NSCLC: Phase 2 Trial Aashi verma12 Feb 2026 8:30 AM ISTCanada: A recent phase 2 trial involving treatment-naive patients found that combining fecal microbiota transplantation (FMT) with immune checkpoint...
Independent Review Supports Safety and Effectiveness of COVID-19, RSV, and Influenza Vaccines for 2025-2026 Aashi verma11 Feb 2026 9:00 PM ISTUSA: A recent systematic review and meta-analysis shows that immunizations against Coronavirus Disease 2019 (COVID-19), respiratory syncytial virus...
Accelerating Action for Women's Health - Ft Rajeev Sibal, President, IRF, Lupin Limited Rajeev Sibal8 March 2025 5:33 PM ISTWomen's health is a multifaceted issue, shaped by socioeconomic factors, cultural influences, and evolving healthcare landscapes. In India, young...
High Rate of Prescription Deviations in Indian Tertiary Hospitals; Experts Recommend Training and Policy Changes Nidhi Srivastava10 Aug 2024 6:45 AM ISTIndia: An article in the Indian Journal of Medical Research has highlighted a recent evaluation of prescription practices in tertiary care...
Up to 3 Months Jail, Rs 2 Lakh Fine if Unregistered Persons Found Operating Pharmacy: Chhattisgarh Pharmacy Council Ruchika Sharma21 May 2024 6:16 PM ISTRaipur: There will be an imprisonment of up to 3 months or a fine of Rs 2 lakh if any unregistered persons are found running a pharmacy or...
Electoral Bonds data: Which Pharma, healthcare company made donations to which party? Meghna A Singhania22 March 2024 6:00 PM ISTNew Delhi: With the State Bank of India (SBI) finally submitting crucial data on the electoral bonds to the Election Commission (EC) yesterday, the EC...
COMPLETE LIST: 37 Pharma, Health Cos bought Electoral Bonds for Rs 903 crore, Yashoda Super Speciality Hospital top buyer with Rs 162 crore Barsha Misra15 March 2024 3:12 PM ISTNew Delhi: Around 37 pharma and healthcare companies bought electoral bonds worth around Rs 903 crore, revealed the data by the Election...
Intas Pharma to commercialise Serplulimab in India Ruchika Sharma30 Oct 2023 3:29 PM ISTSerplulimab will be commercialised by Intas in India and by its subsidiary, Accord Healthcare Ltd, in Europe.
Strides to sell manufacturing facility in Singapore for Rs 125 crore Ruchika Sharma29 Oct 2023 4:00 PM IST"Proceeds from the transaction will be utilized for debt reduction," Strides stated.
NMC lists therapeutic categories of drugs which can be sold sans prescription Kajal Rajput14 Aug 2023 6:33 PM ISTNew Delhi: The National Medical Commission, in its newly notified regulations, has for the first time provided a list of therapeutic categories of...
FDA Approves Colchicine as breakthrough for lowering CVD events Chumbeni22 Jun 2023 10:30 AM ISTUSA: Colchicine 0.5 mg (to be sold as Lodoco) has been approved by the US Food and Drug Administration (FDA), making it the first anti-inflammatory...
Low-Carb, High-Quality Diet Linked to Lower Mortality Rates in People with Type 2 Diabetes, Study Finds Dr. Mahalakshmi Sivashankaran31 March 2023 11:15 AM ISTUSA: New research published in the Diabetes Care Journal suggests that low-carbohydrate diets (LCD) could lower mortality risk in individuals with...
